Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Accuray Incorporated (ARAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 369,350
  • Shares Outstanding, K 83,000
  • Annual Sales, $ 398,800 K
  • Annual Income, $ -25,500 K
  • 36-Month Beta 1.27
  • Price/Sales 1.00
  • Price/Cash Flow N/A
  • Price/Book 8.39

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.35 +2.30%
on 07/21/17
4.90 -9.18%
on 07/17/17
unch (unch)
since 06/21/17
3-Month
3.85 +15.58%
on 05/22/17
4.90 -9.18%
on 07/17/17
-0.20 (-4.30%)
since 04/21/17
52-Week
3.85 +15.58%
on 05/22/17
6.39 -30.36%
on 09/30/16
-0.88 (-16.51%)
since 07/21/16

Most Recent Stories

More News
Medical Equipment Stock Performance Review -- Amedica, Neovasc, Accuray, and NuVasive

If you want a Stock Review on AMDA, NVCN, ARAY, or NUVA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com is currently scanning...

NUVA : 79.92 (-1.47%)
AMDA : 0.42 (+6.06%)
NVCN : 1.24 (-2.36%)
ARAY : 4.45 (-3.26%)
New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers

Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better Cancer-Specific Survival...

ARAY : 4.45 (-3.26%)
Accuray's Q4 Preliminary Results Fail to Cheer Investors

Accuray (ARAY) announced its preliminary results for for the fourth quarter and fiscal 2017. Following the announcement, the company's stock lost over 2% in the last trading session to close at $4.70.

EW : 118.01 (-1.18%)
ARAY : 4.45 (-3.26%)
CRY : 19.15 (-1.29%)
EDAP : 3.20 (+1.59%)
Accuray Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results

Accuray Incorporated (NASDAQ: ARAY) announced today preliminary revenue and product orders for the fourth quarter and full fiscal year ended June 30, 2017, that are in line with guidance provided in April....

ARAY : 4.45 (-3.26%)
Accuray's Medical Systems to be Acquired by Dubai Hospital

Accuray Inc. (ARAY) recently announced that it has signed an agreement with the Neuro Spinal Hospital in Dubai, United Arab Emirates.

EW : 118.01 (-1.18%)
ARAY : 4.45 (-3.26%)
CRY : 19.15 (-1.29%)
EDAP : 3.20 (+1.59%)
Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife and Radixact Systems

SUNNYVALE, California, July 11, 2017 /PRNewswire/ --

ARAY : 4.45 (-3.26%)
Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife® and Radixact(TM) Systems

Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding access to its products in the Middle East with the signing of an agreement with the Neuro Spinal Hospital (NSH) in Dubai, United...

ARAY : 4.45 (-3.26%)
New Strong Sell Stocks for July 10th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

BRS : 7.50 (-4.09%)
AXL : 15.50 (-6.17%)
ARAY : 4.45 (-3.26%)
KOS : 6.23 (-2.81%)
BOBE : 67.12 (-0.58%)
MedTech Thriving on Consolidation & Expansion: Stocks to Buy

MedTech Thriving on Consolidation & Expansion: Stocks to Buy

NVRO : 86.33 (-0.61%)
VAR : 103.88 (-0.45%)
BSX : 27.62 (-0.40%)
ABMD : 144.10 (-0.14%)
TFX : 211.17 (-0.66%)
JNJ : 135.31 (-0.92%)
EGRX : 75.20 (+2.15%)
PAHC : 38.30 (+1.46%)
MASI : 96.19 (-1.11%)
GKOS : 40.33 (-0.84%)
OPK : 6.59 (+2.65%)
INGN : 95.22 (-1.58%)
WMGI : 27.58 (-1.18%)
BCR : 322.22 (+0.10%)
HOLX : 45.01 (-0.88%)
EW : 118.01 (-1.18%)
CYH : 9.27 (+0.11%)
ABT : 50.84 (-0.02%)
BDX : 205.30 (+0.97%)
ARAY : 4.45 (-3.26%)
BAX : 62.67 (-0.59%)
MDT : 85.17 (-0.58%)
DXCM : 69.52 (-0.70%)
Montefiore is First in NY Metropolitan Area to Treat Cancer Patients with Accuray Radixact(TM) System

Accuray Incorporated (NASDAQ: ARAY) and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS), announced today that Montefiore doctors have treated the first cancer...

ARAY : 4.45 (-3.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Support & Resistance

2nd Resistance Point 4.78
1st Resistance Point 4.62
Last Price 4.45
1st Support Level 4.32
2nd Support Level 4.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.